We provide professional GMP compliance gap analysis services tailored for biopharmaceutical manufacturing facilities, process systems and quality management systems, supporting new plant validation, facility renovation, product registration and regulatory inspection preparation. Fully aligned with FDA cGMP, EU GMP and global biomanufacturing compliance criteria, our systematic assessment framework identifies deviations between existing factory conditions and international regulatory standards. Adopting risk-based quality management principles, we deliver audit-ready gap evaluation reports and rectification roadmaps to eliminate hidden compliance risks and ensure full regulatory adaptability for bioproduction operations.
Our comprehensive GMP gap analysis covers all core dimensions of biopharmaceutical compliant operation and management. The assessment scope includes cleanroom environmental conditions, HVAC and utility system stability, process equipment sanitation performance, CIP/SIP validity, bioprocess operation standardization, batch record management, personnel qualification and SOP completeness. We conduct in-depth on-site verification, document review and process parameter auditing to pinpoint non-compliant items, systematic loopholes and operational irregularities. Hierarchical risk grading is performed for all identified gaps, distinguishing critical quality defects, major compliance deviations and minor optimization points to support targeted rectification strategies.
Covering full-lifecycle standardized consulting services, our scope includes pre-inspection comprehensive gap screening, classified gap cause analysis,
customized rectification scheme formulation, priority optimization scheduling, on-site rectification guidance and post-rectification compliance verification.
We deliver complete standardized assessment dossiers, detailed gap lists and implementable improvement roadmaps, covering facility upgrading, process optimization, document system supplementation and staff competency enhancement. Full-process data sorting and traceable rectification records fully meet regulatory audit traceability and continuous compliance improvement requirements.
Empowered by extensive GMP compliance consulting and regulatory service experience, our gap analysis solutions resolve core industry pain points such as blind rectification, incomplete compliance coverage and unaddressed hidden risks. Systematic pre-assessment and targeted optimization effectively reduce inspection failure risks and post-audit rectification costs. Standardized gap closure mechanisms continuously improve enterprise quality management maturity and operational standardization. We help biopharmaceutical enterprises achieve full GMP compliance, stabilize batch production quality and build solid foundations for global market registration and long-term standardized operation.
